Assessment of Cardiorespiratory Fitness Using the Progressive Aerobic Cardiovascular Endurance Run in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever: A Healthy Control Study
| Registry | NCT06697028 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 216 (Actual) |
| Sponsor | Istanbul University - Cerrahpasa (Other) |
| Conditions | Juvenile Idiopathic Arthritis, Familial Mediterranean Fever, Healty Controls |
| Interventions | Usability and Comparison (Other) |
| Dates | start 2024-12-25, primary completion 2025-01-11, completion 2025-05-11, first posted 2024-11-20, last updated 2025-06-05 |
| Locations | 1 site in Turkey (Türkiye) |
Related Papers Related Patents Related Grants Related Experts
All trials for Juvenile Idiopathic Arthritis All trials for Familial Mediterranean Fever All trials of Usability and Comparison
Juvenile Idiopathic Arthritis (JIA) and Familial Mediterranean Fever (FMF) are the most common autoimmune and autoinflammatory rheumatic diseases in childhood. Symptoms such as reduced muscle strength, joint pain, fatigue, and limited activity, which are common in childhood rheumatic diseases, often lead to impaired physical function. Cardiorespiratory fitness, which is an important indicator of physical function, plays a critical role in health-related outcomes in children and adolescents with rheumatic disease. Maximum oxygen consumption (VO2 peak) is considered the fundamental criterion for evaluating cardiorespiratory fitness. The need for extensive equipment and trained personnel, accompanied with the inability to assess large numbers of children at one-time makes the objective assessment of cardiorespiratory fitness in a clinic setting unmanageable. Therefore, there is a need to assess their cardiorespiratory fitness utilizing an easily administered test that has minimal measurement errors in patients with JIA and FMF. The Progressive Aerobic Cardiovascular Endurance Run (PACER) has become a routine cardiorespiratory fitness assessment for predicting VO2peak in children. A review of the literature revealed that no studies have evaluated CRF using PACER in childhood rheumatic diseases. The aim of this study was to compare the Fitnessgram VO2 max values of children and adolescents diagnosed with JIA and FMF with those of their healthy peers and to examine the relationship with body composition.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Juvenile Idiopathic Arthritis | Other: Usability and Comparison | Patients diagnosed with JIA followed at the Pediatric Rheumatology Clinic, Department of Pediatrics, Istanbul Faculty of Medicine, will be evaluated. | |
| Familial Mediterranean Fever | Other: Usability and Comparison | Patients diagnosed with FMF followed at the Pediatric Rheumatology Clinic, Department of Pediatrics, Istanbul Faculty of Medicine, will be evaluated. | |
| Healthy control | Other: Usability and Comparison | The outcomes of individuals with rheumatic diseases will be compared with those of healthy controls. |
Sex: All, ages: 12 Years to 18 Years, accepts healthy volunteers
Inclusion Criteria: * Did not have any chronic disease other than rheumatic disease * Diagnosed with rheumatic disease at least 6 months ago * Had stable medical treatment * Being between the ages of 12 and 18 * Volunteering to participate in the study Exclusion Criteria: * Have experienced trauma or surgery affecting the musculoskeletal system within the last 6 months * Have acute pain for any reason, have visual or hearing problems * Have cognitive impairment * Not volunteering to participate in the study
| Facility | City | Country | Status |
|---|---|---|---|
| Istanbul University-Cerrahpasa | Istanbul | Turkey (Türkiye) |